Filed Pursuant to Rule 424(b)(2)
Registration No. 333-163063
ROSETTA GENOMICS LTD.
We may from time to time offer and sell up to $75,000,000 aggregate dollar amount of ordinary shares, debt securities, warrants and units. We will specify in one or more prospectus supplements the terms of the securities to be offered and sold. We may sell these securities to or through underwriters or dealers and also to other purchasers or through agents. We will set forth the names of any underwriters, dealers or agents in a prospectus supplement.
Our ordinary shares are currently listed on The NASDAQ Capital Market under the symbol “ROSG.” On December 19, 2012, the last reported sale price of our ordinary shares was $4.90 per share. As of December 19, 2012, the aggregate market value of our outstanding ordinary shares held by non-affiliates was approximately $48,643,874, based on 9,096,548 shares of outstanding common stock, of which 9,092,313 shares were held by non-affiliates, and a per share price of $5.35 based on the closing sale price of our ordinary shares on October 22, 2012. We have offered securities with an aggregate market value of approximately $10,152,882, consisting of (1) 540,000 ordinary shares we offered and sold in April 2012 at a public offering price of $2.55 per share, (2) 632,057 ordinary shares we offered and sold in May 2012 at a public offering price of $3.50 per share, and (3) 570,755 ordinary shares we offered and sold in May 2012 at a public offering price of $11.50 per share, pursuant to General Instruction I#$%$ of Form F-3 during the prior 12 calendar month period that ends on, and includes, the date of this prospectus supplement.
Probably will do them at 3.25 to 3.50 per share! It is just a game to them, retailers are mere cannon fodder, probably the guys in Israel have made tens of millions trading, always knowing what is coming before it does. SOMEBODY has gotten wealthy at the expense of retail herd.